3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
7
Leukemia, Myeloid, Acute
6
Graft vs Host Disease
6
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms, Plasma Cell
4
Multiple Myeloma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Hematologic Neoplasms
4
Lymphoma, Mantle-Cell
3
Recurrence
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
Sarcoma, Myeloid
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
fludarabine phosphate
18
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Mycophenolic Acid
11
ruxolitinib
10
Busulfan
10
Tacrolimus
9
Cyclophosphamide
9
fludarabine
6
Methotrexate
5
Melphalan
5
Cyclosporine
5
Hydroxyurea
4
Antilymphocyte Serum
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Prednisone
3
Lenalidomide
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
thymoglobulin
2
peginterferon alfa-2a
2
merphos
2
Surveys and Questionnaires
2
Radiotherapy
2
Imatinib Mesylate
2
Etoposide
2
Dasatinib
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Polycythemia Vera
×
Hematopoietic Stem Cell Transplantation
×
Clear all
No trials found.